You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

m-TOR inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dysphagia, Stroke Trial in Toronto (TOR-BSST© eLearning Training, Standard TOR-BSST© Training)

Recruiting
  • Dysphagia
  • Stroke
  • TOR-BSST© eLearning Training
  • Standard TOR-BSST© Training
  • Toronto, Ontario, Canada
    University Health Network
May 12, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Dalpiciclib Isetionate Tablets, Camrelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Dalpiciclib Isetionate Tablets, Camrelizumab
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Feb 2, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel),

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 17, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Dysbiosis Trial in Graz (Intervention)

Not yet recruiting
  • Dysbiosis
  • Intervention
  • Graz, Austria
    Medical University Graz
Apr 18, 2023

Brain Metastases Trial in Houston (Niraparib, Dostarlimab)

Not yet recruiting
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))

Not yet recruiting
  • Rheumatoid Arthritis
  • Abatacept (M3-M12)
  • +2 more
  • Montpellier, France
    Centre Hospitalier Universitaire de Montpellier
Jun 16, 2022

NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center
May 22, 2023

Atopic Dermatitis Trial in Worldwide (Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1%)

Terminated
Has Results
  • Atopic Dermatitis
  • Crisaborole ointment, 2%
  • +3 more
  • Bryant, Arkansas
  • +31 more
Dec 8, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • (no location specified)
Jan 14, 2023

Metastatic Pancreatic Cancer Trial in Houston (MRTX849)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Shockwave M5+ IVL Catheter in Hostile and Calcified Iliac Access

Not yet recruiting
  • Aortic Diseases
  • +2 more
    • Bologna, Emilia-Romagna, Italy
    • +4 more
    May 19, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • CDK Inhibitor AT7519
    • +3 more
    • Washington, District of Columbia
    • +5 more
    Oct 18, 2022

    Urothelial Cancer Trial run by the NCI (Bintrafusp alfa (M7824))

    Terminated
    Has Results
    • Urothelial Cancer
    • Bintrafusp alfa (M7824)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 25, 2022

    Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)

    Recruiting
    • Colitis
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 17, 2022

    Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

    Terminated
    Has Results
    • Histologically or Cytologically Confirmed Pancreatic Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 19, 2022

    Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

    Not yet recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Mar 9, 2023

    Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)

    Not yet recruiting
    • Endometrial Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 27, 2023

    Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +5 more
    • (no location specified)
    Jan 18, 2023

    Breast Cancer Trial in Houston (Trastuzumab deruxtecan, Valemetostat)

    Not yet recruiting
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 14, 2022

    Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • +2 more
    • Tucson, Arizona
    • +81 more
    Jan 3, 2023